Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Using wallets to keep your crypto safe is essential for security. Discover the best wallet options to secure your investments.
23,072 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
As Zillow prepares for 2026 earnings season, investors crave clarity on growth, margins, and how the housing cycle co...
medicare advantage’s premium comes with a catch that could affect coverage during serious illness. As enrollment tren...
As July 29 approaches, investors eye Microsoft’s Q4 results for a potential breakout. This article lays out why the s...
This guide helps investors decode Workiva's 2025 earnings landscape. Learn which metrics matter, how to read manageme...
Pattern PTRN just released its Q1 2026 earnings, revealing growth drivers and fresh guidance. This analysis breaks do...
CrowdStrike is approaching a stock split, but smart investors look beyond the headline. Here are three solid reasons ...
Karooooo stock jumped today after a solid earnings report that topped expectations. This article breaks down the numb...
Axiom Space has closed a $350 million round to accelerate its private space station project. This milestone highlight...
A focused look at Toast's Q1 2026 results and what they imply for toast (tost) 2026 earnings. Expect discussion of re...
SpaceX just shook the investor world again with a massive bond offering. This article breaks down what spacex's fundr...